[Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]. (2017). Farmeconomia. Health Economics and Therapeutic Pathways, 18(2S). https://doi.org/10.7175/fe.v18i2s.1320